Malassezia and Dandruff-Driven Shedding: The Fungal-Follicle Link

Malassezia species are not passive residents of the scalp. In AGA-prone sebum-rich environments, their metabolic activity drives inflammation that accelerates miniaturisation and shedding.

Malassezia is a genus of obligate lipophilic yeasts that colonise sebaceous skin throughout the body, including the scalp. In their commensal state, they are benign residents. Under conditions of increased sebum availability, compromised skin barrier, or immune dysregulation, specific Malassezia species — particularly M. globosa and M. restricta — become pathological, driving the inflammatory scalp conditions of dandruff and seborrhoeic dermatitis.

The metabolic pathway to inflammation

M. globosa produces lipases that cleave triglycerides in sebum into free fatty acids, including oleic acid. Oleic acid is irritating to the scalp epithelium at the concentrations generated in sebum-rich environments. It penetrates the stratum corneum of the scalp epidermis and follicular keratinocytes, where it activates NF-κB-mediated inflammatory signalling, triggering IL-1β, IL-8, and TNF-α production.

The resulting inflammatory state — seborrhoeic dermatitis in its clinical manifestation — involves scale formation, erythema, and pruritis. The itch-scratch cycle further compromises the scalp barrier, allowing more microbial penetration and maintaining the inflammatory cycle.

How this connects to AGA

The perifollicular inflammation driven by Malassezia metabolites overlaps mechanistically with the microinflammation pathway in AGA. Follicles exposed to chronic low-grade inflammation via M. globosa-derived fatty acids may develop perifollicular lymphocytic infiltrates and subsequent fibrosis — independent of or in addition to DHT-driven miniaturisation.

In practice: a man with both AGA and significant seborrhoeic dermatitis has two independent drivers of follicle compromise — DHT and Malassezia inflammation. Treating only one (typically DHT via finasteride) leaves the second driver unaddressed. Adding ketoconazole shampoo addresses the Malassezia component directly and may provide incremental benefit.

The ketoconazole dual mechanism

Ketoconazole 2% shampoo kills Malassezia through ergosterol synthesis inhibition. But its documented AGA benefit (Piérard-Franchimont 1998 comparison with minoxidil) likely reflects a second mechanism — ketoconazole's direct anti-androgenic activity via 5-AR inhibition and androgen receptor antagonism at the scalp level — operating in addition to the antifungal effect.